{"month":"2024-07","funder":544,"topic":"bioethics","total_keywords":40,"keywords":{"062cef1d":{"keyword":"life sciences","count":2,"weighted_score":1.2,"ad_ids":[72293,72298]},"16081204":{"keyword":"new op_ed","count":3,"weighted_score":1.26,"ad_ids":[72293,72296,72298]},"ce7d9221":{"keyword":"life sciences sector","count":2,"weighted_score":1.2,"ad_ids":[72293,72298]},"8e60f866":{"keyword":"full potential","count":1,"weighted_score":1.13,"ad_ids":[72293]},"a7558b63":{"keyword":"life sciences ontario","count":1,"weighted_score":1.13,"ad_ids":[72293]},"0d3b9129":{"keyword":"public drug formulary","count":1,"weighted_score":1.13,"ad_ids":[72293]},"6ef48595":{"keyword":"jason field","count":1,"weighted_score":1.13,"ad_ids":[72293]},"de99085a":{"keyword":"commercial environment","count":1,"weighted_score":1.13,"ad_ids":[72293]},"408c7c58":{"keyword":"canada","count":2,"weighted_score":1.2,"ad_ids":[72293,72298]},"f6b64076":{"keyword":"ontario","count":1,"weighted_score":1.13,"ad_ids":[72293]},"63bd7065":{"keyword":"life","count":2,"weighted_score":1.2,"ad_ids":[72293,72298]},"49eeb723":{"keyword":"new medicine","count":1,"weighted_score":1.13,"ad_ids":[72293]},"c7749952":{"keyword":"annie th\u00e9riault","count":1,"weighted_score":1.13,"ad_ids":[72296]},"3d804971":{"keyword":"healthcare","count":1,"weighted_score":1.13,"ad_ids":[72296]},"dbe5ff00":{"keyword":"birth control pill","count":1,"weighted_score":1.13,"ad_ids":[72296]},"a36c93a2":{"keyword":"significant opportunity","count":1,"weighted_score":1.13,"ad_ids":[72296]},"c9952ea1":{"keyword":"development funding","count":1,"weighted_score":1.13,"ad_ids":[72296]},"fe2a4030":{"keyword":"impact investing","count":1,"weighted_score":1.13,"ad_ids":[72296]},"ca98c3c6":{"keyword":"critical gap","count":1,"weighted_score":1.13,"ad_ids":[72296]},"106346f8":{"keyword":"address these disparities","count":1,"weighted_score":1.13,"ad_ids":[72296]},"6bef98fc":{"keyword":"international collaboration","count":1,"weighted_score":1.13,"ad_ids":[72296]},"0d9738b8":{"keyword":"cross_border impact ventures","count":1,"weighted_score":1.13,"ad_ids":[72296]},"fe75ca00":{"keyword":"canadian investment industry","count":1,"weighted_score":1.13,"ad_ids":[72296]},"6aa3083f":{"keyword":"managing partner","count":1,"weighted_score":1.13,"ad_ids":[72296]},"604ba54a":{"keyword":"pfizer_biontech covid_19 vaccine","count":1,"weighted_score":1.13,"ad_ids":[72296]},"51485e11":{"keyword":"crucial area","count":1,"weighted_score":1.13,"ad_ids":[72296]},"bfba7033":{"keyword":"critical","count":1,"weighted_score":1.13,"ad_ids":[72296]},"8f494122":{"keyword":"global scale","count":1,"weighted_score":1.13,"ad_ids":[72298]},"d4b14619":{"keyword":"top life sciences economy","count":1,"weighted_score":1.13,"ad_ids":[72298]},"7dca44ad":{"keyword":"life_saving technologies","count":1,"weighted_score":1.13,"ad_ids":[72298]},"3e305349":{"keyword":"gene editing","count":1,"weighted_score":1.13,"ad_ids":[72298]},"18501020":{"keyword":"strong history","count":1,"weighted_score":1.13,"ad_ids":[72298]},"62d7b573":{"keyword":"economic opportunities","count":1,"weighted_score":1.13,"ad_ids":[72298]},"4ea0dd8f":{"keyword":"new medications","count":1,"weighted_score":1.13,"ad_ids":[72298]},"0ac006af":{"keyword":"andrew macisaac","count":1,"weighted_score":1.13,"ad_ids":[72298]},"08e5c355":{"keyword":"life sciences research","count":1,"weighted_score":1.13,"ad_ids":[72298]},"dcaa8e5e":{"keyword":"machine learning","count":1,"weighted_score":1.13,"ad_ids":[72298]},"552b81e4":{"keyword":"applied pharmaceutical innovation","count":1,"weighted_score":1.13,"ad_ids":[72298]},"51bc3058":{"keyword":"strategic investments","count":1,"weighted_score":1.13,"ad_ids":[72298]},"290a5b26":{"keyword":"fosters innovation","count":1,"weighted_score":1.13,"ad_ids":[72298]}}}